Emergent Growth Fund

Total investments

9

Average round size

3M

Portfolio companies

6

Rounds per year

0.47

Follow on index

0.33

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologySoftwareHealth Care3D TechnologyMedicalNational SecurityIntelligent SystemsTherapeuticsHardwareClinical Trials

Summary

Emergent Growth Fund is the famous VC, which was founded in 2003. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the Gainesville.

The overall number of key employees were 2.

The top activity for fund was in 2007. The fund is constantly included in less than 2 investment rounds annually. Considering the real fund results, this VC is 8 percentage points less often commits exit comparing to other organizations. The common things for fund are deals in the range of 1 - 5 millions dollars.

Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, Hardware. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Clinipace, Bit Cauldron, Prioria Robotics

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Emergent Growth Fund, startups are often financed by ATDC, Virgo Investment Group, Perella Weinberg Partners. The meaningful sponsors for the fund in investment in the same round are Hatteras Venture Partners, Georgia Venture Partners, ATDC. In the next rounds fund is usually obtained by ATDC, OUP (Osage University Partners), Morgan Stanley.

Show more

Investments analytics

Analytics

Total investments
9
Lead investments
0
Rounds per year
0.47
Follow on index
0.33
Investments by industry
  • Medical (4)
  • Biotechnology (3)
  • Health Care (3)
  • Software (3)
  • Clinical Trials (2)
  • Show 8 more
Investments by region
  • United States (9)
Peak activity year
2008

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
17
Group Appearance index
0.56

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Wilmington Pharmaceuticals 26 Oct 2006 Biotechnology, Health Care Early Stage Venture 1M United States, North Carolina, Wilmington

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.